The global infection control market size reached USD 28.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 49.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.22% during 2025-2033. The rapid technological advancements in diagnostic and infection control equipment, the increasing demand in veterinary and animal care settings, the rising research and development in infectious disease prevention, and the growing focus on preventing healthcare-associated infections (HAIs) are some of the factors propelling the market.
Report Attribute
|
Key Statistics |
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 28.1 Billion |
Market Forecast in 2033
|
USD 49.7 Billion |
Market Growth Rate 2025-2033
|
6.22% |
Increasing Geriatric Population
There has been a significant increase in the geriatric population. For instance, according to the World Health Organization (WHO), by 2030, one in every six persons in the world will be 60 or older. At this time, the proportion of the population aged 60 and up will rise from 1 billion in 2020 to nearly 1.4 billion in 2030. By 2050, the global population of persons aged 60 and up will double (approx. 2.1 billion). This demographic trend drives the demand for infection control measures, particularly in long-term care facilities, nursing homes, and hospitals, where older patients require rigorous infection prevention protocols. These factors further positively influence the infection control market forecast.
Rising Prevalence of Healthcare-Associated Infections (HAI)
The rise in healthcare-associated infections across various regions, such as surgical site infections, catheter-related infections, and ventilator-associated pneumonia, is a significant factor driving the demand for infection control measures in healthcare settings. For instance, according to an article published by the European Centre for Disease Prevention and Control, every year, nearly 4.3 million patients in EU/EEA hospitals contract at least one healthcare-associated infection. The need to reduce the prevalence of these infections is leading to greater investments in infection control products and technologies. These factors are expected to propel the infection control market share in the coming years.
Expanding Ambulatory Services Industry
The increasing trend towards ambulatory services has created new opportunities for infection control products. For instance, according to IMARC, the global ambulatory services market size reached US$ 3.8 Trillion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.3 Trillion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. These facilities require effective infection control measures due to the high patient turnover and the need to ensure a safe environment for both patients and staff, thereby boosting the infection control market revenue.
IMARC Group provides an analysis of the key trends in each segment of the global infection control market report, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on type and end user.
Breakup by Type:
Consumables dominate the market
The report has provided a detailed breakup and analysis of the market based on the type. This includes equipment (disinfectors (washers, flushers, and ultrasonic cleaners), sterilization equipment (heat sterilization, low temperature sterilization, radiation sterilization, and filtration-based sterilization) and others), services (contract sterilization (ETO sterilization, gamma sterilization, e-beam sterilization, and steam sterilization), and infectious waste disposal), and consumables (disinfectants, sterilization consumables, personal protective equipment, and others). According to the report, consumables represented the largest segment.
According to the infection control market outlook, the consumables segment, including disinfectants, sterilization consumables, personal protective equipment (PPE), and other related products, is the largest market segment in the industry. These consumables play a critical role in preventing and controlling the spread of infections across various sectors, such as healthcare, food processing, and public spaces. Disinfectants are vital in healthcare facilities, laboratories, and public spaces to eliminate harmful pathogens on surfaces and minimize the risk of infections. Sterilization consumables, like autoclave bags and indicator tapes, are indispensable in maintaining sterile medical instruments and equipment conditions.
Breakup by End User:
Hospitals and clinics dominate the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and clinics, medical device companies, clinical laboratories, pharmaceutical companies, and others. According to the report, hospitals and clinics represented the largest segment.
According to the infection control market overview, the hospitals and clinics segment emerged as the largest market share holder in the industry, reflecting the critical role of infection prevention measures in healthcare settings. Hospitals and clinics are high-risk environments where vulnerable patients, healthcare professionals, and visitors come into close contact, making them susceptible to infectious diseases. Infection control is of utmost importance in these settings to curb the spread of healthcare-associated infections (HAIs) and safeguard patient safety. Strict protocols, including hand hygiene, sterilization of medical equipment, and the use of personal protective equipment (PPE), are integral to maintaining a safe and sterile environment. Besides this, with a growing focus on patient care, hospital accreditation, and regulatory compliance, the demand for these solutions in hospitals and clinics remains robust. As healthcare facilities strive to enhance infection prevention measures and reduce the burden of HAIs, the hospitals and clinics segment is expected to continue leading the market.
Breakup by Region:
North America exhibits a clear dominance, accounting for the largest infection control market share
The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Russia, and Others); Europe (Germany, France, the United Kingdom, Italy, Spain, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
According to the infection control market statistics, North America, comprising the United States and Canada, dominate the market, which can be attributed to several key factors driving its growth. The region's significant aging population contributes to the rising demand for infection control measures. For instance, according to an article published by the Population Reference Bureau, the number of people in the United States aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050 (a 47% increase), with the 65-and-over age group accounting for 17% to 23% of the overall population. Moreover, the region's technologically advanced healthcare infrastructure fosters the adoption of innovative infection control solutions, including advanced disinfectants, sterilization technologies, and smart medical devices.
Top companies catalyze the market by introducing innovative solutions and technologies to combat infectious diseases. These companies invest heavily in research and development, creating cutting-edge disinfection and sterilization products that effectively prevent the spread of infections. Their commitment to maintaining stringent quality standards and adherence to regulatory guidelines instills trust among healthcare providers, bolstering their market presence. Moreover, these companies actively engage in educational programs and awareness campaigns, emphasizing the importance of infection prevention and control measures. Continued efforts to expand their global footprint through strategic collaborations and acquisitions further fuel market growth. They address environmental concerns and attract environmentally-conscious consumers by prioritizing sustainability and eco-friendly practices.
The infection control market research report has provided a comprehensive analysis of the competitive landscape in the infection control market. Detailed profiles of all major companies have also been provided.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Types Covered |
|
End Users Covered | Hospitals and Clinics, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | 3M Company, Advanced Sterlization Products Services Inc. (Fortive Corporation), Belimed AG (Metall Zug), Cantel Medical Corp., Getinge AB, Matachana, Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.), MMM Münchener Medizin Mechanik GmbH, Pal International, Sterigenics U.S. LLC (Sotera Health Holdings LLC), Steris Corporation, TSO3 Inc. (Stryker Corporation) etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |